Global Pulmonary Drugs Market Analysis 2016-2020 and Forecast 2021-2026
Global Pulmonary Drugs Market Analysis 2016-2020 and Forecast 2021-2026
Analysis of the Pulmonary Drugs Market reveals emerging trends, consumer adoption rates, and competitive strategies among leading manufacturers worldwide.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The global Pulmonary Drugs market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Pulmonary Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Inhaled Corticosteroids (ICS)
Long-Acting Beta2-Agonists (LABA)
Antihistamine
Vasodilators
Short-Acting Beta2-Agonists (SABA)
Anticholinergics
Combination Drugs
MAbs
Enzymes
Antibiotics & Antileukotrienes
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
AstraZeneca plc
Bayer AG
Teva Pharmaceutical Industries Ltd
Actelion Pharmaceuticals, Inc.
Boehringer Ingelheim GmbH
F. Hoffmann-La Roche Ltd.
Merck & Co., Inc.
Novartis AG
GlaxoSmithKline plc
Sunovion Pharmaceuticals
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Asthma & COPD
Allergic Rhinitis
Pulmonary Arterial Hypertension
Cystic Fibrosis
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
1 Industry Overview
1.1 Pulmonary Drugs Industry
Figure Pulmonary Drugs Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Pulmonary Drugs
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Pulmonary Drugs
1.2.2 Downstream
Table Application Segment of Pulmonary Drugs
Table Global Pulmonary Drugs Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Pulmonary Drugs Market by Type
3.1 By Type
3.1.1 Inhaled Corticosteroids (ICS)
Table Major Company List of Inhaled Corticosteroids (ICS)
3.1.2 Long-Acting Beta2-Agonists (LABA)
Table Major Company List of Long-Acting Beta2-Agonists (LABA)
3.1.3 Antihistamine
Table Major Company List of Antihistamine
3.1.4 Vasodilators
Table Major Company List of Vasodilators
3.1.5 Short-Acting Beta2-Agonists (SABA)
Table Major Company List of Short-Acting Beta2-Agonists (SABA)
3.1.6 Anticholinergics
Table Major Company List of Anticholinergics
3.1.7 Combination Drugs
Table Major Company List of Combination Drugs
3.1.8 MAbs
Table Major Company List of MAbs
3.1.9 Enzymes
Table Major Company List of Enzymes
3.1.10 Antibiotics & Antileukotrienes
Table Major Company List of Antibiotics & Antileukotrienes
3.2 Market Size
Table Global Pulmonary Drugs Market 2016-2020, by Type, in USD Million
Figure Global Pulmonary Drugs Market Growth 2016-2020, by Type, in USD Million
Table Global Pulmonary Drugs Market 2016-2020, by Type, in Volume
Figure Global Pulmonary Drugs Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Pulmonary Drugs Market Forecast 2021-2026, by Type, in USD Million
Table Global Pulmonary Drugs Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 AstraZeneca plc (Company Profile, Sales Data etc.)
4.1.1 AstraZeneca plc Profile
Table AstraZeneca plc Overview List
4.1.2 AstraZeneca plc Products & Services
4.1.3 AstraZeneca plc Business Operation Conditions
Table Business Operation of AstraZeneca plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Bayer AG (Company Profile, Sales Data etc.)
4.2.1 Bayer AG Profile
Table Bayer AG Overview List
4.2.2 Bayer AG Products & Services
4.2.3 Bayer AG Business Operation Conditions
Table Business Operation of Bayer AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Teva Pharmaceutical Industries Ltd (Company Profile, Sales Data etc.)
4.3.1 Teva Pharmaceutical Industries Ltd Profile
Table Teva Pharmaceutical Industries Ltd Overview List
4.3.2 Teva Pharmaceutical Industries Ltd Products & Services
4.3.3 Teva Pharmaceutical Industries Ltd Business Operation Conditions
Table Business Operation of Teva Pharmaceutical Industries Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Actelion Pharmaceuticals, Inc. (Company Profile, Sales Data etc.)
4.4.1 Actelion Pharmaceuticals, Inc. Profile
Table Actelion Pharmaceuticals, Inc. Overview List
4.4.2 Actelion Pharmaceuticals, Inc. Products & Services
4.4.3 Actelion Pharmaceuticals, Inc. Business Operation Conditions
Table Business Operation of Actelion Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Boehringer Ingelheim GmbH (Company Profile, Sales Data etc.)
4.5.1 Boehringer Ingelheim GmbH Profile
Table Boehringer Ingelheim GmbH Overview List
4.5.2 Boehringer Ingelheim GmbH Products & Services
4.5.3 Boehringer Ingelheim GmbH Business Operation Conditions
Table Business Operation of Boehringer Ingelheim GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 F. Hoffmann-La Roche Ltd. (Company Profile, Sales Data etc.)
4.6.1 F. Hoffmann-La Roche Ltd. Profile
Table F. Hoffmann-La Roche Ltd. Overview List
4.6.2 F. Hoffmann-La Roche Ltd. Products & Services
4.6.3 F. Hoffmann-La Roche Ltd. Business Operation Conditions
Table Business Operation of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Merck & Co., Inc. (Company Profile, Sales Data etc.)
4.7.1 Merck & Co., Inc. Profile
Table Merck & Co., Inc. Overview List
4.7.2 Merck & Co., Inc. Products & Services
4.7.3 Merck & Co., Inc. Business Operation Conditions
Table Business Operation of Merck & Co., Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Novartis AG (Company Profile, Sales Data etc.)
4.8.1 Novartis AG Profile
Table Novartis AG Overview List
4.8.2 Novartis AG Products & Services
4.8.3 Novartis AG Business Operation Conditions
Table Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 GlaxoSmithKline plc (Company Profile, Sales Data etc.)
4.9.1 GlaxoSmithKline plc Profile
Table GlaxoSmithKline plc Overview List
4.9.2 GlaxoSmithKline plc Products & Services
4.9.3 GlaxoSmithKline plc Business Operation Conditions
Table Business Operation of GlaxoSmithKline plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Sunovion Pharmaceuticals (Company Profile, Sales Data etc.)
4.10.1 Sunovion Pharmaceuticals Profile
Table Sunovion Pharmaceuticals Overview List
4.10.2 Sunovion Pharmaceuticals Products & Services
4.10.3 Sunovion Pharmaceuticals Business Operation Conditions
Table Business Operation of Sunovion Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Pulmonary Drugs Sales Revenue 2016-2020, by Company, in USD Million
Table Global Pulmonary Drugs Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Pulmonary Drugs Sales Revenue Share in 2020, by Company, in USD Million
Table Global Pulmonary Drugs Sales Volume 2016-2020, by Company, in Volume
Table Global Pulmonary Drugs Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Pulmonary Drugs Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Pulmonary Drugs Market Concentration, in 2020
Figure Europe Pulmonary Drugs Market Market Concentration, in 2020
Figure Asia-Pacific Pulmonary Drugs MMarket Concentration, in 2020
Figure South America Pulmonary Drugs Market Concentration, in 2020
Figure Middle East & Africa Pulmonary Drugs Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Asthma & COPD
Figure Pulmonary Drugs Demand in Asthma & COPD, 2016-2020, in USD Million
Figure Pulmonary Drugs Demand in Asthma & COPD, 2016-2020, in Volume
6.1.2 Demand in Allergic Rhinitis
Figure Pulmonary Drugs Demand in Allergic Rhinitis, 2016-2020, in USD Million
Figure Pulmonary Drugs Demand in Allergic Rhinitis, 2016-2020, in Volume
6.1.3 Demand in Pulmonary Arterial Hypertension
Figure Pulmonary Drugs Demand in Pulmonary Arterial Hypertension, 2016-2020, in USD Million
Figure Pulmonary Drugs Demand in Pulmonary Arterial Hypertension, 2016-2020, in Volume
6.1.4 Demand in Cystic Fibrosis
Figure Pulmonary Drugs Demand in Cystic Fibrosis, 2016-2020, in USD Million
Figure Pulmonary Drugs Demand in Cystic Fibrosis, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Pulmonary Drugs Demand Forecast 2021-2026, by Application, in USD Million
Figure Pulmonary Drugs Market Growth 2021-2026, by Application, in USD Million
Figure Pulmonary Drugs Market Share in 2026, by Application, in USD Million
Table Pulmonary Drugs Demand Forecast 2021-2026, by Application, in Volume
Table Pulmonary Drugs Market Growth 2021-2026, by Application, in Volume
Table Pulmonary Drugs Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Pulmonary Drugs Production 2016-2020, by Region, in USD Million
Table Pulmonary Drugs Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Pulmonary Drugs Market 2016-2020, by Region, in USD Million
Table Global Pulmonary Drugs Market Share 2016-2020, by Region, in USD Million
Table Global Pulmonary Drugs Market 2016-2020, by Region, in Volume
Table Global Pulmonary Drugs Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Pulmonary Drugs Market Size and Growth 2016-2020, in USD Million
Figure North America Pulmonary Drugs Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Pulmonary Drugs Market Size 2016-2020, by Country, in USD Million
Table North America Pulmonary Drugs Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Pulmonary Drugs Market Size and Growth 2016-2020, in USD Million
Figure Europe Pulmonary Drugs Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Pulmonary Drugs Market Size 2016-2020, by Country, in USD Million
Table Europe Pulmonary Drugs Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Pulmonary Drugs Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Pulmonary Drugs Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Pulmonary Drugs Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Pulmonary Drugs Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Pulmonary Drugs Market Size and Growth 2016-2020, in USD Million
Figure South America Pulmonary Drugs Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Pulmonary Drugs Market Size 2016-2020, by Country, in USD Million
Table South America Pulmonary Drugs Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Pulmonary Drugs Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Pulmonary Drugs Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Pulmonary Drugs Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Pulmonary Drugs Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Pulmonary Drugs Market Forecast 2021-2026, by Region, in USD Million
Table Pulmonary Drugs Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
Research Methodology:
Pulmonary Drugs Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|